Kanda S. Ramasamy

586 total citations
25 papers, 463 citations indexed

About

Kanda S. Ramasamy is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Kanda S. Ramasamy has authored 25 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 8 papers in Organic Chemistry and 7 papers in Infectious Diseases. Recurrent topics in Kanda S. Ramasamy's work include DNA and Nucleic Acid Chemistry (11 papers), Biochemical and Molecular Research (10 papers) and HIV/AIDS drug development and treatment (7 papers). Kanda S. Ramasamy is often cited by papers focused on DNA and Nucleic Acid Chemistry (11 papers), Biochemical and Molecular Research (10 papers) and HIV/AIDS drug development and treatment (7 papers). Kanda S. Ramasamy collaborates with scholars based in United States. Kanda S. Ramasamy's co-authors include D R Averett, Susan M. Freier, Robert C. Tam, Zhi Hong, W. Seifert, Michael Griffith, P. Dan Cook, Lisa M. Risen, Jean‐Luc Girardet and Esmir Gunić and has published in prestigious journals such as Nucleic Acids Research, Annals of the New York Academy of Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Kanda S. Ramasamy

25 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kanda S. Ramasamy United States 13 323 152 102 66 62 25 463
Danuta Madej Canada 8 202 0.6× 157 1.0× 153 1.5× 157 2.4× 69 1.1× 10 414
David Dukhan France 8 134 0.4× 88 0.6× 140 1.4× 185 2.8× 153 2.5× 17 339
Mei‐Zhen Luo United States 9 276 0.9× 163 1.1× 243 2.4× 130 2.0× 34 0.5× 21 454
Abdesslem Faraj France 10 188 0.6× 152 1.0× 203 2.0× 177 2.7× 129 2.1× 19 443
Galegov Ga Russia 11 139 0.4× 98 0.6× 89 0.9× 169 2.6× 11 0.2× 103 382
Kirupa Shanmuganathan United States 8 215 0.7× 149 1.0× 236 2.3× 166 2.5× 85 1.4× 9 478
Monica Donghi Italy 13 163 0.5× 249 1.6× 113 1.1× 38 0.6× 49 0.8× 19 399
Christopher J. Yarnold United Kingdom 7 119 0.4× 98 0.6× 61 0.6× 93 1.4× 17 0.3× 9 270
Alain Pompon France 16 602 1.9× 230 1.5× 463 4.5× 148 2.2× 41 0.7× 38 866
Stephen A. Fakhoury United States 8 251 0.8× 215 1.4× 296 2.9× 36 0.5× 15 0.2× 10 541

Countries citing papers authored by Kanda S. Ramasamy

Since Specialization
Citations

This map shows the geographic impact of Kanda S. Ramasamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kanda S. Ramasamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kanda S. Ramasamy more than expected).

Fields of papers citing papers by Kanda S. Ramasamy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kanda S. Ramasamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kanda S. Ramasamy. The network helps show where Kanda S. Ramasamy may publish in the future.

Co-authorship network of co-authors of Kanda S. Ramasamy

This figure shows the co-authorship network connecting the top 25 collaborators of Kanda S. Ramasamy. A scholar is included among the top collaborators of Kanda S. Ramasamy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kanda S. Ramasamy. Kanda S. Ramasamy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gunić, Esmir, Jean‐Luc Girardet, Kanda S. Ramasamy, et al.. (2007). Cyclic monophosphate prodrugs of base-modified 2′-C-methyl ribonucleosides as potent inhibitors of hepatitis C virus RNA replication. Bioorganic & Medicinal Chemistry Letters. 17(9). 2452–2455. 32 indexed citations
2.
Gunić, Esmir, Kanda S. Ramasamy, Anneke K. Raney, et al.. (2007). 6-Hydrazinopurine 2′-methyl ribonucleosides and their 5′-monophosphate prodrugs as potent hepatitis C virus inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(9). 2456–2458. 20 indexed citations
3.
Ramasamy, Kanda S., Jean‐Luc Girardet, Esmir Gunić, et al.. (2006). Synthesis of pyrrolo[2,3-d]pyrimidine nucleoside derivatives as potential anti-HCV agents. Bioorganic Chemistry. 35(1). 25–34. 41 indexed citations
4.
Ramasamy, Kanda S., et al.. (2006). Synthesis of 2-amino-2,4-anhydro-3-O-(2-tetrahydropyranyl)-psicofuranose: a versatile intermediate for S-type locked nucleosides. Tetrahedron Letters. 47(8). 1283–1285. 3 indexed citations
5.
Ramasamy, Kanda S., et al.. (2006). Synthesis of some monocyclic-N-acetyl 4′-aza-D-nucleosides. Journal of Heterocyclic Chemistry. 43(2). 325–336. 4 indexed citations
6.
Ramasamy, Kanda S., et al.. (2005). Solid-phase Parallel Synthesis of 4-β-D-Ribofuranosylpyrazolo[4,3-d]pyrimidine Nucleosides. Nucleosides Nucleotides & Nucleic Acids. 24(10-12). 1947–1970. 6 indexed citations
7.
Ramasamy, Kanda S. & Johnson Y. N. Lau. (2001). A NEW SYNTHETIC METHODOLOGY FOR TIAZOFURIN. Nucleosides Nucleotides & Nucleic Acids. 20(4-7). 1329–1331. 7 indexed citations
8.
Ramasamy, Kanda S., et al.. (2000). Monocyclicl-Nucleosides with Type 1 Cytokine-Inducing Activity. Journal of Medicinal Chemistry. 43(5). 1019–1028. 33 indexed citations
9.
Ramasamy, Kanda S., et al.. (2000). A New Synthetic Methodology for Tiazofurin. The Journal of Organic Chemistry. 65(18). 5849–5851. 34 indexed citations
10.
11.
Ramasamy, Kanda S., et al.. (1999). A Simple and Convenient Method for the Deprotection of Tetrahydropyranyl Ether Using Iodine in Methanol. Synthetic Communications. 29(16). 2881–2894. 10 indexed citations
12.
13.
Ramasamy, Kanda S. & D R Averett. (1999). A Modified Synthesis of Tiazofurin. Nucleosides and Nucleotides. 18(11-12). 2425–2431. 4 indexed citations
14.
Averett, D R, et al.. (1999). Synthesis and structural studies of monocyclic 4′-Aza-L-Nucleosides. Tetrahedron. 55(47). 13345–13368. 11 indexed citations
15.
Ramasamy, Kanda S., et al.. (1999). Synthesis and Biophysical Studies of Modified Oligonucleotides Containing Acyclic Amino Alcohol Nucleoside Analogs. Nucleosides and Nucleotides. 18(8). 1845–1861. 2 indexed citations
16.
Zhang, Weijian, Kanda S. Ramasamy, & D R Averett. (1999). Improved Synthesis of 2-Deoxy-L-ribose. Nucleosides and Nucleotides. 18(11-12). 2357–2365. 13 indexed citations
17.
Baker, Brenda F., Kanda S. Ramasamy, & John S. Kiely. (1996). Decapitation of a 5' capped RNA by an antisense copper complex conjugate. Bioorganic & Medicinal Chemistry Letters. 6(14). 1647–1652. 12 indexed citations
18.
Griffith, Michael, et al.. (1995). Inhibition of NF-κB specific transcriptional activation by PNA strand invasion. Nucleic Acids Research. 23(15). 3003–3008. 64 indexed citations
19.
20.
Manoharan, Muthiah, D. P. C. MCGEE, Charles J. Guinosso, et al.. (1992). Chemical Modifications to Improve Uptake and Bioavailability of Antisense Oligonucleotides. Annals of the New York Academy of Sciences. 660(1). 306–309. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Danuta Madej Breakdown of academic impact, for papers by David Dukhan Breakdown of academic impact, for papers by Mei‐Zhen Luo Breakdown of academic impact, for papers by Abdesslem Faraj Breakdown of academic impact, for papers by Galegov Ga Breakdown of academic impact, for papers by Kirupa Shanmuganathan Breakdown of academic impact, for papers by Monica Donghi Breakdown of academic impact, for papers by Christopher J. Yarnold Breakdown of academic impact, for papers by Alain Pompon Breakdown of academic impact, for papers by Stephen A. Fakhoury
Rankless by CCL
2026